|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
40 Guest St,Boston,Massachusetts,US
|
|
NextRNA Therapeutics, Inc. is a MA-based newly founded biotechnology company committed to leading the next revolution of RNA-directed therapeutics. Based on the foundational work of Carl Novina at Dana-Farber Cancer Institute, NextRNA has established a proprietary target and drug discovery engine that enables us to systematically identify disease-relevant long non-coding RNAs and their interacting proteins, and develop selective small molecules to drug RNA-protein interactions.
The company is currently advancing two small molecule therapeutic programs in oncology and immunology.
NextRNA has assembled a highly experienced and competent team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
|
NextRNA Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used NextRNA Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact NextRNA Therapeutics customer service number in your country click here to find.
Dominique Verhelle is the CEO of NextRNA Therapeutics. To contact Dominique Verhelle email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.